Sicheri, Frank
Mount Sinai Hospital · University of Toronto · Lunenfeld-Tanenbaum Research Institute · Sinai Health System
10 papers on CoChatORCID 0000-0002-9824-2117
Most cited papers
- Verified
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
Isho, B., Abe, K. T., Zuo, M., Jamal, A. J., Rathod, B., Wang, J. H., Li, Z., Chao, G., Rojas, O. L., Bang, Y. M., et al. (2020) · Science Immunology
SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing
Cited by 822
- Verified
53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark
Fradet-Turcotte, A., Canny, M. D., Escribano-Díaz, C., Orthwein, A., Leung, C. C. Y., Huang, H., Landry, M.-C., Kitevski-LeBlanc, J., Noordermeer, S. M., Sicheri, F., et al. (2013) · Nature
DNA Repair MechanismsGenomics and Chromatin Dynamics
Cited by 686
- Verified
A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein
Goudreault, M., D'Ambrosio, L. M., Kean, M. J., Mullin, M. J., Larsen, B. G., Sanchez, A., Chaudhry, S., Chen, G. I., Sicheri, F., Nesvizhskii, A. I., et al. (2009) · Molecular & Cellular Proteomics
Protein Kinase Regulation and GTPase SignalingVascular Malformations Diagnosis and Treatment
Cited by 359
- Verified
Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1
Nakada, S., Tai, I., Panier, S., Al-Hakim, A., Iemura, S.-I., Juang, Y.-C., O’Donnell, L., Kumakubo, A., Munro, M., Sicheri, F., et al. (2010) · Nature
Ubiquitin and proteasome pathwaysDNA Repair Mechanisms
Cited by 357
- Verified
Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase
Hunter, R. W., Hughey, C. C., Lantier, L., Sundelin, E. I., Peggie, M., Zeqiraj, E., Sicheri, F., Jessen, N., Wasserman, D. H., & Sakamoto, K. (2018) · Nature Medicine
Metabolism, Diabetes, and CancerDiabetes Treatment and Management
Cited by 313
- Verified
Inhibition of RAS function through targeting an allosteric regulatory site
Spencer-Smith, R., Koide, A., Zhou, Y., Eguchi, R. R., Sha, F., Gajwani, P., Santana, D., Gupta, A., Jacobs, M., Herrero-Garcia, E., et al. (2017) · Nature Chemical Biology
Protein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways
Cited by 283
- Verified
Suprafacial Orientation of the SCFCdc4 Dimer Accommodates Multiple Geometries for Substrate Ubiquitination
Tang, X., Orlicky, S., Lin, Z., Willems, A., Neculai, D., Ceccarelli, D., Mercurio, F., Shilton, B. H., Sicheri, F., & Tyers, M. (2007) · Cell
Ubiquitin and proteasome pathwaysProtein Degradation and Inhibitors
Cited by 209
- Verified
A feed forward loop enforces YAP/TAZ signaling during tumorigenesis
Gill, M. K., Christova, T., Zhang, Y. Y., Gregorieff, A., Zhang, L., Narimatsu, M., Song, S., Xiong, S., Couzens, A. L., Tong, J., et al. (2018) · Nature Communications
Hippo pathway signaling and YAP/TAZCancer-related molecular mechanisms research
Cited by 95
- Verified
Structural basis for the recruitment of glycogen synthase by glycogenin
Zeqiraj, E., Tang, X., Hunter, R. W., García-Rocha, M., Judd, A., Deak, M., von Wilamowitz-Moellendorff, A., Kurinov, I., Guinovart, J. J., Tyers, M., et al. (2014) · Proceedings of the National Academy of Sciences
Glycogen Storage Diseases and MyoclonusMetabolism, Diabetes, and Cancer
Cited by 57
- Verified
Getting a handle on glycogen synthase – Its interaction with glycogenin
Zeqiraj, E., & Sicheri, F. (2015) · Molecular Aspects of Medicine
Glycogen Storage Diseases and MyoclonusMetabolism, Diabetes, and Cancer
Cited by 42
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free